These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26439987)

  • 1. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.
    Ramalinga M; Roy A; Srivastava A; Bhattarai A; Harish V; Suy S; Collins S; Kumar D
    Oncotarget; 2015 Oct; 6(33):34446-57. PubMed ID: 26439987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1.
    Tian S; Guo X; Yu C; Sun C; Jiang J
    Oncotarget; 2017 Feb; 8(7):11071-11082. PubMed ID: 28052003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
    Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
    Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
    Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
    Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
    Guan B; Wu K; Zeng J; Xu S; Mu L; Gao Y; Wang K; Ma Z; Tian J; Shi Q; Guo P; Wang X; He D; Du Y
    Oncotarget; 2017 Jan; 8(5):8162-8172. PubMed ID: 28030804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.
    Kumar P; Sharad S; Petrovics G; Mohamed A; Dobi A; Sreenath TL; Srivastava S; Biswas R
    Oncotarget; 2016 Apr; 7(16):22791-806. PubMed ID: 26988912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
    Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.
    Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.
    Bucay N; Sekhon K; Yang T; Majid S; Shahryari V; Hsieh C; Mitsui Y; Deng G; Tabatabai ZL; Yamamura S; Calin GA; Dahiya R; Tanaka Y; Saini S
    Oncogene; 2017 May; 36(19):2667-2679. PubMed ID: 27893706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 and microRNAs: The role in breast, lung and prostate cancers.
    Karbasforooshan H; Roohbakhsh A; Karimi G
    Exp Cell Res; 2018 Jun; 367(1):1-6. PubMed ID: 29574020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
    Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
    Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells.
    Wang X; Yang B; Ma B
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1025-1031. PubMed ID: 27686228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.